Maximus publishes a dedicated sermorelin help collection alongside a broader growth hormone peptide storefront. That gives prospective patients useful information about clinical review, pharmacy fulfillment, and support. It also creates an important shopping question: which exact medication and plan does the displayed price describe?
This review examines public material checked on September 20, 2026. We did not enroll, purchase medication, test a vial, or measure patient results. CoreAge Rx receives commercial placement on this site; the comparison below evaluates published information and unanswered questions rather than declaring a clinical winner.
Maximus publishes useful care and refill details. Confirm the selected sermorelin product, total commitment, and monitoring costs before treating a broader peptide price as your quote.
Start with the sermorelin-specific help material
The dedicated protocol overview describes a subcutaneous injection and clinician assessment. Its role is different from a general article explaining why people explore growth hormone treatment. Use the specific patient information to frame questions about the proposed prescription, then ask for the actual label and instructions if treatment is prescribed.
Do not assume every medicine mentioned on a shared growth hormone page is sermorelin. Tesamorelin appears in the broader discussion and is a different molecule. A category page can help you discover options, but the decision belongs to the named product. Our sermorelin versus tesamorelin guide explains why this distinction changes the evidence comparison.
The displayed plan rates need a product check
The broader growth hormone peptide storefront displayed $299.99 per month for a one-month plan, $274.99 per month for a two-month plan, and $199.99 per month for a six-month plan. It qualifies pricing by dose, plan length, and state. We have not verified which selected sermorelin order receives each figure or what is charged upfront.
Request a quote that names the medication, quantity, care term, total due now, and later charges. A six-month monthly equivalent is a way to describe a price, not proof of monthly cancellation rights. If a lower rate depends on a longer commitment, ask what happens if the clinician recommends stopping before the term ends.
Make the laboratory plan explicit
The storefront advertises IGF-1 testing availability through Maximus Labs. Availability is not the same as inclusion in every medication plan. Ask whether the clinician recommends baseline or follow-up testing for your situation, where it takes place, and whether it costs extra.
Also ask what a result would change. An increased IGF-1 value does not by itself demonstrate better sleep, stronger muscles, or improved memory. A useful monitoring discussion connects a test to a clinical decision and to the concern that brought you to care. Read the laboratory guide before choosing a plan primarily because a biomarker feature sounds reassuring.
Clinical questions and account questions take different paths
Maximus's shipping help page separates clinician responsibilities from customer support. It describes clinician review for renewals and notes that symptom updates or laboratory work may be requested when appropriate. The page directs prescription and symptom questions to the clinician, while support handles issues such as tracking and account access.
That separation is helpful, but a published workflow does not establish an actual response time. Ask how to reach the clinical team after a new side effect, what happens outside routine hours, and whether follow-up is scheduled. If you prefer a phone conversation to portal messages, establish that option before paying rather than assuming it will be available later.
Read outcome claims as claims, not promises
The storefront makes broad statements about recovery, appearance, sleep, and body composition. A mechanism involving the body's own growth hormone does not establish a guaranteed result or eliminate risk. A provider's rating of an aesthetic benefit is also different from a validated outcome in a controlled trial.
Ask for research on the exact intervention and the outcome you care about. Some frequently cited GHRH cognition trials used tesamorelin; others examine a different secretagogue altogether. The clinical-studies article follows those distinctions. This review has not found a basis for converting Maximus's marketing comparisons into a proven safety ranking against other providers.
Know the shipment and refill procedure
The help material says a clinician-approved prescription goes to a partner pharmacy and tracking is available through the portal. It advises contacting support about delayed tracking or compromised shipments. We did not test shipment timing, packing performance, or replacement handling.
Before delivery, identify the dispensing pharmacy and read the storage instructions for the actual preparation. Ask whom to contact if the package arrives late or damaged. A service's shipping description cannot establish a universal temperature window for all compounded products. The shipping guide helps you document a problem without guessing whether a vial remains usable.
Resolve state access and the full care relationship
Maximus ties prescribing availability to the patient's physical location and clinician licensure. If you spend part of the year in another state, ask how that affects visits, refills, and shipping. A permanent home address is not necessarily the location where a remote appointment takes place.
For a reader over 50, coordination with existing care may matter as much as checkout convenience. Bring diabetes, thyroid, pituitary, and other relevant history to the assessment. Ask whether the service can share records with your usual clinician. A straightforward intake is useful only if the clinical information needed for a sound decision is also available.
Our assessment and the next comparison
Maximus offers more published operational detail than a simple product card, especially around the distinction between support and clinical follow-up. The main unresolved purchasing issues are the exact sermorelin quote, what monitoring costs, and the selected plan's cancellation and replacement terms. Those are questions to answer before interpreting the program as a complete package.
Compare its written quote with another service using the same period of care. The CoreAge Rx review supplies a separate starting point, with the same limitations on advertised prices and clinical claims. If neither option explains the diagnosis or the expected benefit clearly, a consultation to investigate the symptom may be the more useful next step.
Our CoreAge Rx versus Maximus comparison puts product selection, monitoring, and refill arrangements side by side.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- Maximus: Sermorelin protocol overviewProvider help center · Sermorelin-specific administration and care information; not independent outcome evidence.
- Maximus: Growth hormone peptidesProvider product page · Contains multiple peptide options; prices depend on selected product, dose, state and term. Clinical claims are marketing, not independent comparisons.
- DailyMed: EGRIFTA WR prescribing informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
- Endotext: Growth Hormone and AgingExpert clinical evidence review · Separates hormone and body-composition findings from functional outcomes and long-term unknowns.
- Maximus: Sermorelin prescriptions, refills and shippingProvider help center · Explains clinician review, pharmacy fulfillment and support roles; not a tested service guarantee.
- FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
- Baker et al.: GHRH and cognitive function, controlled trial (2012)Human randomized controlled study · 152 enrolled adults; 20 weeks of tesamorelin, not sermorelin. Cognitive outcomes are not dementia prevention.
- Sigalos and Pastuszak: Safety and efficacy of growth hormone secretagoguesClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- FDA: Safe drug use after a natural disasterUS regulator · General temperature-exposure guidance. Does not establish a sermorelin stability window or injectable reconstitution method.
- HHS: Telehealth licensing across state linesUS government guidance · Licensure options depend on the patient location and state rules.
- Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- CoreAge Rx: Sermorelin product pageProvider primary source · Live product page; starting price is not a verified checkout total.